Lyka Labs Limited (BOM: 500259)

Market Cap	5.31B
Revenue (ttm)	1.27B
Net Income (ttm)	32.76M
Shares Out	n/a
EPS (ttm)	0.93
PE Ratio	162.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,109
Open	150.75
Previous Close	154.45
Day's Range	148.00 - 155.60
52-Week Range	99.95 - 175.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 17, 2025

About Lyka Labs

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-mal...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 423
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500259

Financial Performance

In 2023, Lyka Labs's revenue was 1.06 billion, an increase of 18.75% compared to the previous year's 894.17 million. Losses were -25.98 million, -80.50% less than in 2022.